Role of glycosylation on the ensemble of conformations in the MUC1 immunodominant epitope

被引:2
|
作者
Singh, Jaideep [1 ]
Her, Cheenou [1 ]
Supekar, Nitin [2 ,3 ]
Boons, Geert-Jan [2 ,3 ,4 ,5 ]
Krishnan, Viswanathan V. [1 ,6 ]
Brooks, Cory L. [1 ]
机构
[1] Calif State Univ Fresno, Dept Chem, 2555 E San Ramon Ave, Fresno, CA 93740 USA
[2] Univ Georgia, Dept Chem, 140 Cedar St, Athens, GA 30602 USA
[3] Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA USA
[4] Univ Utrecht, Dept Chem Biol & Drug Discovery, Utrecht Inst Pharmaceut Sci, Univ Weg 99, NL-3584 CG Utrecht, Netherlands
[5] Univ Utrecht, Bijvoet Ctr Biomol Res, Univ Weg 99, NL-3584 CG Utrecht, Netherlands
[6] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Davis, CA 95616 USA
关键词
antibody-antigen; ensemble; glycobiology; immunotherapy; mucin; NMR; O-GLYCOSYLATION; MONOCLONAL-ANTIBODY; CANCER VACCINES; PHASE-I; PROTEIN; RECOGNITION; PEPTIDE; BINDING; TANDEM; ANTIGEN;
D O I
10.1002/psc.3229
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MUC1 is a membrane glycoprotein, which in adenocarninomas is overexpressed and exhibits truncated O-glycosylation. Overexpression and altered glycosylation make MUC1 into a candidate for immunotherapy. Monoclonal antibodies directed against MUC1 frequently bind an immunodominant epitope that contains a single site for O-glycosylation. Glycosylation with tumor carbohydrate antigens such as the Tn-antigen (GalNAc-O-Ser/Thr) results in antibodies binding with higher affinity. One proposed model to explain the enhanced affinity of antibodies for the glycosylated antigen is that the addition of a carbohydrate alters the conformational properties, favoring a binding-competent state. The conformational effects associated with Tn glycosylation of the MUC1 antigen was investigated using solution-state NMR and molecular dynamics. NMR experiments revealed distinct substructures of the glycosylated MUC1 peptides compared with the unglycosylated peptide. Molecular dynamics simulations of the MUC1 glycopeptide and peptide revealed distinguishing differences in their conformational preferences. Furthermore, the glycopeptide displayed a smaller conformational sampling compared with the peptide, suggesting that the glycopeptide sampled a narrower conformational space and is less dynamic. A comparison of the computed ensemble of conformations assuming random distribution, NMR models, and molecular dynamics simulations indicated that the MUC1 glycopeptide and aglycosylated peptide sampled structurally distinctly ensembles and that these ensembles were different from that of the random coil. Together, these data support the hypothesis that that conformational pre-selection could be an essential feature of these peptides that dictates the binding affinities to MUC1 specific antibodies.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Generation of antibodies that target and kill MUC1 expressing cancer cells via a novel cell-tethered MUC1 α/β junction epitope
    Karmely, M.
    Rubinstein, D. B.
    Wreschner, D. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state
    Altschuler, Y
    Kinlough, CL
    Poland, PA
    Bruns, JB
    Apodaca, G
    Weisz, OA
    Hughey, RP
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (03) : 819 - 831
  • [33] Differential glycosylation of MUC1 in tumors and transfected epithelial and lymphoblastoid cell lines
    Poland, PA
    Kinlough, CL
    Rokaw, MD
    MagarianBlander, J
    Finn, OJ
    Hughey, RP
    GLYCOCONJUGATE JOURNAL, 1997, 14 (01) : 89 - 96
  • [34] Differential glycosylation of MUC1 in tumors and transfected epithelial and lymphoblastoid cell lines
    P. A Poland
    C. L Kinlough
    M. D Rokaw
    J Magarian-Blander
    O. J Finn
    R. P Hughey
    Glycoconjugate Journal, 1997, 14 : 89 - 96
  • [35] Effects of glycosylation on fragments of tumour associated human epithelial mucin MUC1
    Braun, P
    Davies, GM
    Price, MR
    Williams, PM
    Tendler, SJB
    Kunz, H
    BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (09) : 1531 - 1545
  • [36] Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells
    Brockhausen, I.
    Yang, J.-M.
    Burchell, J.
    Whitehouse, C.
    European Journal of Biochemistry, 233 (02):
  • [37] MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERα) in regulation of the MUC1 gene expression
    Joseph Z Zaretsky
    Itay Barnea
    Yael Aylon
    Marat Gorivodsky
    Daniel H Wreschner
    Iafa Keydar
    Molecular Cancer, 5
  • [38] MUC1 and cancer
    Taylor-Papadimitriou, J
    Burchell, J
    Miles, DW
    Dalziel, M
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1999, 1455 (2-3): : 301 - 313
  • [39] Running a MUC1
    Nicola McCarthy
    Nature Reviews Cancer, 2012, 12 : 317 - 317
  • [40] Expression of MUC1 mucin on activated human T cells: Implications for a role of MUC1 in normal immune regulation
    Agrawal, B
    Krantz, MJ
    Parker, J
    Longenecker, BM
    CANCER RESEARCH, 1998, 58 (18) : 4079 - 4081